Zhaoke Ophthalmology (06622) Releases January 2026 Monthly Return
Bulletin Express
Feb 03
Zhaoke Ophthalmology Limited (06622) issued its monthly return for the period ended January 31, 2026. The report shows that the company's authorized share capital remained unchanged at USD 400,000, with 1,600,000,000,000 ordinary shares at a par value of USD 0.00000025 per share.
According to the filing, the total number of issued shares stayed at 547,970,012, with no treasury shares reported. The data also confirms compliance with the applicable public float requirement. Details in the share option schemes indicate that no new shares were issued through option exercises during the month. No other movements in issued shares, treasury shares, warrants, or convertible securities were disclosed.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.